RoosterBio, Inc. Deal History & Licensing Activity
RoosterBio, Inc. is a life sciences. Over the past three years, RoosterBio, Inc. has been involved in 1 licensing and acquisition transaction, with a primary focus on Cell Therapy (2 deals).
Deals (12mo)
0
Active Trials
0
Top Modality
Cell Therapy
Focus Area
Other
RoosterBio, Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving RoosterBio, Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CliniControl™ cGMP media platforms and research-grade bioprocessing media | MineBio Life Sciences Limited | Cell Therapy | Approved | license | Apr 2026 |
RoosterBio, Inc. Pipeline Focus
Therapeutic areas and modalities where RoosterBio, Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
RoosterBio, Inc. Strategic Signals
Key indicators of RoosterBio, Inc.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches RoosterBio, Inc.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Cell Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for cell therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About RoosterBio, Inc. Licensing & Deal Activity
RoosterBio, Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, RoosterBio, Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for RoosterBio, Inc. include Other (2 deals and trials). In terms of modality, RoosterBio, Inc. has shown particular interest in cell therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for RoosterBio, Inc. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against RoosterBio, Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.